Skip to main content
OpenTrials

Clinical trial condition

Female Urogenital Diseases and Pregnancy Complications

Explore clinical trials studying Female Urogenital Diseases and Pregnancy Complications. Study availability and eligibility vary by location and protocol.

27,085 public trials 4,556 recruiting studies
Refine in advanced search Browse all conditions

Female Urogenital Diseases and Pregnancy Complications trial results

Recruiting

Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System

NCT04065438

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Focal Segmental Glomerulosclerosis, +7 more
Locations
  • Loma Linda University Children's Hospital Loma Linda, California, United States
  • Loma Linda University Hospital Loma Linda, California, United States
  • Nemours/Alfred I DuPont Hospital for Children Wilmington, Delaware, United States
  • Helen DeVos Children's Hospital Grand Rapids, Michigan, United States
View Trial Details
Recruiting

A Study to Find and Confirm Blood-based Markers (Called Proteins) That May Show Early Heart Changes in Women With Preeclampsia, Even Before Symptoms Appear, and the Use of Heart Ultrasound (Echocardiography) to Look at Patterns of How the Heart Changes During Pregnancy in Women With Preeclampsia

NCT07463898

Conditions
Cardiovascular Biomarkers, Female Urogenital Diseases and Pregnancy Complications, Hypertension, Pregnancy-Induced, +5 more
Locations
  • University of Abuja Teaching Hospital Abuja, Nigeria
View Trial Details
Recruiting

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

NCT06582017

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Cancer, +54 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer Los Angeles, California, United States
  • Cedars-Sanai Medical Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport, California, United States
View Trial Details
Recruiting

A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

NCT07186842

Conditions
Adnexal Diseases, Advanced Solid Cancers, Bile Duct Diseases, +29 more
Locations
  • SCRI at HCA Health One Denver, Colorado, United States
  • Florida Cancer Specialists Orlando, Florida, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Monash Health Clayton, Australia
View all 17 locations
View Trial Details
Recruiting

Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors

NCT07660055

Conditions
Bladder Cancer, Breast Cancer, Breast Diseases, +24 more
Locations
  • Novartis Investigative Site Darlinghurst, New South Wales, Australia
  • Novartis Investigative Site Montreal, Quebec, Canada
  • Nebraska Cancer Specialists Omaha, Nebraska, United States
  • Novartis Investigative Site Montreal, Quebec, Canada
View Trial Details

Related conditions